InvestorsHub Logo
Followers 3
Posts 177
Boards Moderated 0
Alias Born 04/27/2018

Re: GD post# 32912

Sunday, 08/16/2020 1:43:11 PM

Sunday, August 16, 2020 1:43:11 PM

Post# of 43787
Your point 5B totally misses the point. The concept here is to treat with mk to enhance the activity of the native immune system, and to do so requires treatment prior to SOC modalities. If that’s your concept, why would you start treating in metastatic and recurrent cases where the native immune system has already been damaged? I don’t get your point.

As far as your prediction of the outcome, meh. We shall see soon enough.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News